Nutriband is primarily engaged in the development of a portfolio of transdermal(delivered through the skin) pharmaceutical products.
Our lead product is our AVERSA technology. AVERSA™ abuse deterrent transdermal technology incorporates aversive agents to prevent the Abuse, DiVERsion, MiSuse and Accidental exposure of drugs with abuse potential specifically Opioids. Our first application for AVERSA is for our abuse deterrent...
Nutriband is primarily engaged in the development of a portfolio of transdermal(delivered through the skin) pharmaceutical products.
Our lead product is our AVERSA technology. AVERSA™ abuse deterrent transdermal technology incorporates aversive agents to prevent the Abuse, DiVERsion, MiSuse and Accidental exposure of drugs with abuse potential specifically Opioids. Our first application for AVERSA is for our abuse deterrent fentanyl transdermal patch which we are developing to provide clinicians and patients with an extended release chronic pain relief.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.